Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Versus Placebo for Bipolar Disorder
NCT07472075Phase 2Recruiting
- Start
- May 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in bipolar disorder (BD). Started May 2026; status: recruiting.
02
Drugs
melatonin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT07472075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472075.